Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 1

Todd Neale

May 30, 2022

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

News Daily News

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

L.A. McKeown

January 25, 2022

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

L.A. McKeown

October 02, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for October

Todd Neale

October 01, 2020

News Daily News

COVID-19 Autopsies Hint at Direct Viral Infection of the Heart

L.A. McKeown

July 30, 2020

News Daily News

COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight

L.A. McKeown

May 26, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Caitlin E. Cox

March 26, 2020

News Daily News

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Michael O'Riordan

March 20, 2020

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Daily News

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Caitlin E. Cox

June 29, 2017

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Industry News

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

June 02, 2015

Advertisement

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

November 2022 News Roundup

COVID-19: TCTMD’s Dispatch for June Week 1

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

COVID-19: TCTMD’s Daily Dispatch for October

COVID-19 Autopsies Hint at Direct Viral Infection of the Heart

COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Biomedical Research in CVD: More Investment Today Will Yield Long-term Rewards

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content